Metabolic syndrome and symptom burden in allogeneic hematopoietic stem cell transplantation survivors.

Introduction: Allogeneic hematopoietic stem cell transplantation (HCT) improves survival of patients with hematologic malignancies. A growing responsibility exists to identify and address long-term morbidity and symptom burden. We investigated metabolic syndrome and symptom burden in adult HCT survivors.